Clinical trial · Observational
A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Participants will a diagnosis of gastroesophageal junction (GEJ) adenocarcinoma and will have either a minimally invasive proximal gastrectomy (MIPG) or a minimally invasive total gastrectomy (MITG) as part of their routine care. Participants with complete a questionnaire 1 month before the surgical procedure and then 1, 3, 6 and 12 months after the surgical procedure.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| GastroEsophageal Cancer | Gastric Neoplasm | PROBABILISTIC | 0.70 |
| Gastroesophageal Junction Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MDASI-GI | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Minimally Invasive Proximal Gastrectomy/MIPG
- description
- Participants will undergo MIPG (Trial Procedure)
- interventionNames
- Other: MDASI-GI
- label
- Minimally Invasive Total Gastrectomy/MITG
- description
- Participants will undergo MITG (Standard of Care/Control Group)
- interventionNames
- Other: MDASI-GI
Primary outcomes (1)
- measure
- Appetite level score according to the MDASI-GI
- timeFrame
- 3 months after surgery
- description
- The primary outcome is the appetite level score (with 0 being the best and 10 being the worst) according to the MDASi-GI at 3 months after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Able to speak and read English, Spanish, Japanese or Korean * Patients with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention * Age ≥ 18 Exclusion Criteria: * Patients with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract * Patients with known narcotic dependence, with average daily dose \> 5 mg oral morphine equivalent * Subjects deemed unable to comply with study and/or follow-up procedures, at investigators' discretion * Patients who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)
References
Publications (0)
Data not yet available